VIE Equity Snapshot

BMYS Weekly Equity Report

Bristol-Myers Squibb Company

Interactive chart JSON snapshot
Latest Close 49.29 EUR 12 Jun 2026
1W Return -1.2% latest completed week
4W Return 1.7% short-term follow-through
12W Return 0.4% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive …

Snapshot

What the weekly tape is saying

BMYS closed the latest completed week at 49.29 EUR. The 4-week return is 1.7% and the 12-week return is 0.4%. Trend Signal is active, Market Dynamics is -0.86. Setup signature: Balanced read with a 42/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 2.4%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 75 Persistence of active Trend Signal over the last year and current streak.
Momentum 54 Blend of 4-week and 12-week follow-through.
Dynamics 31 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 19 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 71 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
48.15 EUR
Vs Trend Line
2.4%
Fair Value
43.91 EUR
Vs Fair Value
12.3%
52W High
52.94 EUR
52W Low
35.59 EUR
Drawdown
-6.9%
Range Position
79.0%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.2%
4W 1.7%
12W 0.4%
26W 12.9%
52W 20.1%

Trend read

Active Streak
28 weeks
52W Active Weeks
28
52W Active Breadth
53.8%
Sector Scope
AT Healthcare
Sector Rank
59 of 112
Sector Percentile
47.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.86
4W MD Change
-44.5%
Relative Strength
-7.21
4W RS Change
-111.0%
Expectation
Undecided
Probability
54.02%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
83
52W Average
177
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.6%
52W Volatility
3.7%
Upside Weeks
28
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
3.1% / -2.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
EUR
Market Cap
100.1B

Opportunity signals

  • Trend Signal is active with a 28-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 49.29 EUR -1.2% 48.15 EUR 43.91 EUR -0.86 -7.21 0 On
5 Jun 2026 49.90 EUR 2.9% 47.82 EUR 43.93 EUR -0.86 -3.71 0 On
29 May 2026 48.50 EUR -5.3% 47.47 EUR 43.94 EUR -0.86 -7.58 10 On
22 May 2026 51.22 EUR 5.7% 47.15 EUR 43.97 EUR -0.55 0.06 192 On
15 May 2026 48.46 EUR 1.4% 46.67 EUR 43.97 EUR -0.60 -3.42 0 On
8 May 2026 47.78 EUR -6.7% 46.26 EUR 43.99 EUR -0.39 -5.27 0 On
1 May 2026 51.21 EUR 2.6% 45.90 EUR 44.03 EUR -0.22 2.85 709 On
24 Apr 2026 49.93 EUR -1.7% 45.45 EUR 44.04 EUR -0.18 0.71 0 On
17 Apr 2026 50.79 EUR 1.5% 44.97 EUR 44.06 EUR 0.04 -1.28 0 On
10 Apr 2026 50.04 EUR -3.2% 44.51 EUR 44.08 EUR 0.19 -0.78 0 On
3 Apr 2026 51.69 EUR 2.1% 44.13 EUR 44.11 EUR 0.60 8.58 0 On
27 Mar 2026 50.61 EUR 3.1% 43.68 EUR 44.14 EUR 0.96 9.27 170 On
20 Mar 2026 49.09 EUR -3.7% 43.28 EUR 44.16 EUR 1.36 6.92 2 On
13 Mar 2026 51.00 EUR 0.1% 42.96 EUR 44.19 EUR 1.73 8.93 10 On